Orthofix Medical (NASDAQ:OFIX) Major Shareholder Juniper Investment Company, Ll Acquires 14,803 Shares of Stock

Key Points

• Major shareholder Juniper Investment Company bought 14,803 Orthofix shares at an average $7.04, bringing its holdings to about 4.46 million shares. The purchase followed a separate acquisition of 675,000 shares on November 9.
• Orthofix shares traded at $6.94, near the stock’s 1-year low of $6.52; its 50-day and 200-day moving averages were $9.16 and $10.89, respectively.
• Quarterly EPS of a $0.15 loss beat estimates, but revenue of $207.86 million fell short of consensus. Analysts’ overall rating was Hold, with an average price target of $14.75.

Orthofix Medical Inc. (NASDAQ:OFIX - Get Free Report) major shareholder Juniper Investment Company, Ll purchased 14,803 shares of the business's stock in a transaction on Wednesday, November 11th. The stock was purchased at an average price of $7.04 per share, with a total value of $104,213.12. Following the purchase, the insider owned 4,461,019 shares of the company's stock, valued at approximately $31,405,573.76. The trade was a 0.33% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.

Juniper Investment Company, Ll also recently made the following trade(s):

• On Monday, November 9th, Juniper Investment Company, Ll acquired 675,000 shares of Orthofix Medical stock. The stock was purchased at an average cost of $7.41 per share, with a total value of $5,001,750.00.

Orthofix Medical Stock Performance

Shares of Orthofix Medical stock traded down $0.24 during trading on Thursday, hitting $6.94. 560,217 shares of the stock were exchanged, compared to its average volume of 375,534. The stock has a market capitalization of $282.69 million, a price-to-earnings ratio of -6.20 and a beta of 0.66. The company has a fifty day moving average price of $9.16 and a 200-day moving average price of $10.89. Orthofix Medical Inc. has a 1-year low of $6.52 and a 1-year high of $16.42. The company has a current ratio of 3.11, a quick ratio of 1.67 and a debt-to-equity ratio of 0.55.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last issued its earnings results on Monday, November 9th. The medical device company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $0.11. Orthofix Medical had a negative net margin of 5.39% and a negative return on equity of 10.32%. The business had revenue of $207.86 million during the quarter, compared to the consensus estimate of $210.52 million. As a group, equities analysts predict that Orthofix Medical Inc. will post -1.29 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on OFIX shares. Weiss Ratings lowered Orthofix Medical from a "sell (d-)" rating to a "sell (e+)" rating in a research note on Tuesday, November 3rd. Canaccord Genuity Group reduced their target price on Orthofix Medical from $18.00 to $13.00 and set a "buy" rating for the company in a research note on Monday, August 10th. Finally, TD Cowen reissued a "hold" rating on shares of Orthofix Medical in a report on Tuesday. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $14.75.

Institutional Trading of Orthofix Medical

Hedge funds have recently modified their holdings of the stock. BlackRock Inc. acquired a new position in Orthofix Medical in the 2nd quarter valued at about $30,405,000. Paradigm Capital Management Inc. NY bought a new position in Orthofix Medical in the 2nd quarter valued at about $30,167,000. Bank of America Corp DE bought a new position in Orthofix Medical in the 2nd quarter valued at about $2,667,000. Engine Capital Management LP lifted its position in Orthofix Medical by 3.2% during the first quarter. Engine Capital Management LP now owns 4,390,779 shares of the medical device company's stock worth $50,362,000 after acquiring an additional 137,858 shares during the last quarter. Finally, Great Lakes Advisors LLC acquired a new stake in Orthofix Medical during the second quarter worth approximately $1,236,000. Institutional investors and hedge funds own 89.76% of the company's stock.

About Orthofix Medical

Orthofix Medical Inc. develops and markets medical technologies for spine and orthopedic care. Its products include spinal implants and biologics, bone growth stimulation systems, and solutions used in fracture treatment and limb reconstruction. The company serves hospitals, surgeons, and other health care providers through its Orthofix and SeaSpine businesses. Its offerings span surgical products as well as noninvasive and specialized orthopedic treatments. Orthofix and SeaSpine completed a merger in 2023, combining their spine and orthopedic product portfolios.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.